Hallmark biotech investment firm Third Rock Ventures bolsters its ranks with new venture partners
Third Rock Ventures, a renowned biotech investment firm, has announced the addition of three new venture partners to its team. The firm has also promoted two existing members. The new additions include Steve Paul, M.D., the co-founder of Karuna Therapeutics, who recently sold his company to Bristol Myers Squibb. This move marks a reunion for Paul, who had previously helped launch other companies supported by Third Rock Ventures.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
